<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1262">
  <stage>Registered</stage>
  <submitdate>11/07/2006</submitdate>
  <approvaldate>12/07/2006</approvaldate>
  <actrnumber>ACTRN12606000296538</actrnumber>
  <trial_identification>
    <studytitle>To compare the effect of meals rich in thermally oxidised polyunsaturated fat and saturated fat on circulating numbers of endothelial microparticles</studytitle>
    <scientifictitle>To compare the effect of meals rich in thermally oxidised polyunsaturated fat and saturated fat on circulating numbers of endothelial microparticles</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Healthy subjects</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Administer meals rich in (a) thermally oxidised polyunsaturated sunflower oil, (b) unoxidised native sunflower oil, (c) cream.  The meals will be administered at the rate of one per week and they will be given in random order.   The total duration of the study will be 3 weeks.</interventions>
    <comparator>unoxidized native sunflower oil</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in numbers of endothelial microparticles in the blood during 3 hour postprandial period. </outcome>
      <timepoint>The outcome will be measured at 1 h and at 3 h after the meals.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in markers of oxidative stress including plasma peroxides and nitrotyrosine. </outcome>
      <timepoint>These variables will be measured at baseline and 1 h and 3 h after the meals.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Men and women aged 20-70 years</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Serious illnesses, smoke cigarettes, taking medications or antioxidant supplements.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation schedule held by independent person</concealment>
    <sequence>Simple randomisation of each individual to one of 6 meal sequences using randomisation table from a statistics book.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>Comparison of three different meals</designfeatures>
    <endpoint>Bio-equivalence</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/08/2006</anticipatedstartdate>
    <actualstartdate>15/08/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>25/02/2008</actualenddate>
    <samplesize>25</samplesize>
    <actualsamplesize>25</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Otago Medical Research Foundation</primarysponsorname>
    <primarysponsoraddress>Otago Medical Research Foundation Inc
PO Box 1245
Dunedin
New Zealand</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Otago Medical Research Foundation</fundingname>
      <fundingaddress>Otago Medical Research Foundation Inc
PO Box 1245
Dunedin
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Laurenson Award</fundingname>
      <fundingaddress>Otago Medical Research Foundation Inc
PO Box 1245
Dunedin 
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Otago</sponsorname>
      <sponsoraddress>University of Otago
PO Box 56
Dunedin
New Zealand</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Fatty fast food meals markedly and acutely increase circulating numbers of endothelial cell microparticles (EMPs) that are a marker of endothelial damage. These meals are usually rich in saturated fat and oxidized lipids that may adversely affect the vascular endothelium. Our study aims to compare the effect of ingesting heated polyunsaturated fats (PUFA) enriched in oxidized lipids, and unheated PUFA and saturated fat on circulating number of EMPs in healthy subjects.  The findings of the study may indicate whether dietary advice that includes increased PUFA consumption and use in cooking needs to be modified.</summary>
    <trialwebsite />
    <publication>Sutherland WHF, de Jong SA, Hessian PA, Williams MJA.  ingestion of native and thermally oxidized polyunsaturated fats acutely increases circulating numbers of endothelial microparticles.  Metabolism 2010; 59: 446-453.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Medicine Section Dunedin Hospital-Lower South Reginal Ethics Committee</ethicname>
      <ethicaddress>9th Floor Dunedin Hospital Dunedin</ethicaddress>
      <ethicapprovaldate>18/04/2006</ethicapprovaldate>
      <hrec>LRS/06/02/003</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Wayne HF Sutherland</name>
      <address>Endocrinology Research Unit
Department of Medicine
University of Otago
PO Box 56
Dunedin
New Zealand</address>
      <phone>+64 3 474 0999</phone>
      <fax>+64 3 4747641</fax>
      <email>wayne.sutherland@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Wayne HF Sutherland</name>
      <address>Endocrinology Research Unit
Department of Medicine
University of Otago
PO Box 56
Dunedin
New Zealand</address>
      <phone>+64 3 474 0999</phone>
      <fax>+64 3 4747641</fax>
      <email>wayne.sutherland@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Wayne Sutherland</name>
      <address>Endocrinology Research Unit
Department of Medicine
University of Otago
PO Box 56
Dunedin
New Zealand</address>
      <phone>+64 3 474 0999</phone>
      <fax>+64 3 474 7641</fax>
      <email>wayne.sutherland@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Wayne HF Sutherland</name>
      <address>Endocrinology Research Unit
Department of Medicine
University of Otago
PO Box 56
Dunedin
New Zealand</address>
      <phone>+64 3 474 0999 </phone>
      <fax>+64 3 4747641</fax>
      <email>wayne.sutherland@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>